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Abstract
Current data suggests an association between elevations in interleukin 1 (IL-1)α, IL-1β, and IL-6
and the proliferation of neural progenitor cells (NPCs) following brain injury. A limited amount of
work implicates changes in these pro-inflammatory responses with diminished NPC proliferation
observed as a function of aging. In the current study, adolescent (21 day-old) and 1 yr-old CD1
male mice were injected with trimethyltin (TMT, 2.3 mg/kg, i.p.) to produce acute apoptosis of
hippocampal dentate granule cells. In this model, fewer 5-bromo-2′-deoxyuridine (BrdU)+ NPC
were observed in both naive and injured adult hippocampus as compared to the corresponding
number seen in adolescent mice. At 48 h post-TMT, a similar level of neuronal death was
observed across ages, yet activated amoeboid microglia were observed in the adolescent and
hypertrophic process-bearing microglia in the adult. IL-1α mRNA levels were elevated in the
adolescent hippocampus; IL-6 mRNA levels were elevated in the adult. In subgranular zone (SGZ)
isolated by laser-capture microdissection, IL-1β was detected but not elevated by TMT, IL-1α was
elevated at both ages, while IL-6 was elevated only in the adult. Naïve NPCs isolated from the
hippocampus expressed transcripts for IL-1R1, IL-6Rα, and gp-130 with significantly higher
levels of IL-6Rα mRNA in the adult. In vitro, IL-1α (150pg/ml) stimulated proliferation of
adolescent NPCs; IL-6 (10ng/ml) inhibited proliferation of adolescent and adult NPCs. Microarray
analysis of SGZ post-TMT indicated a prominence of IL-1α/IL-1R1 signaling in the adolescent
and IL-6/gp130 signaling in the adult.
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Adult hippocampal neurogenesis is initiated with the proliferation of neural progenitor cells
(NPCs) within the subgranular zone (SGZ) of the dentate gyrus leading to the formation of
new dentate granule neurons. Regulation of this process in the normal control brain and
following injury occurs via numerous secreted factors such as hormones (Cameron and
Gould, 1994), neurotransmitters (Banasr et al., 2004; Yoshimizu and Chaki, 2004), growth
factors (Aberg et al., 2000; Larsson et al., 2002), and cytokines (Das and Basu, 2008;
Kaneko et al., 2006; Mathieu et al., 2010; Taupin, 2008). Though not fully understood at this
time, regulation of this process through either cellular components such as microglia and
astrocytes (Alvarez-Buylla and Lim, 2004) or secreted factors is known to be critical for
hippocampal neurogenesis following brain injury, and is thought to contribute to the
capacity for “self-repair” of the dentate granule neurons (Ming and Song, 2005).
Associated with the regulation of NPCs in the hippocampus following injury is often the
concurrent activation of microglia. Microglia serve as the resident immune cells of the brain
and upon injury they shift to a reactive phenotype (Davalos et al., 2005; Nimmerjahn et al.,
2005). Upon activation these cells produce pro-inflammatory cytokines including
interleukin-1β (IL-1β), interleukin-1α (IL-1α), and interleukin-6 (IL-6) (Mrak and Griffin,
2005). Overall, the literature indicates IL-1β, IL-1α, and IL-6 adversely affects neurogenesis
by altering proliferation, survival, differentiation, and functional aspects of NPCs (Ajmone-
Cat et al., 2010; Das and Basu, 2008; Mathieu et al., 2010). Recent studies examining the
specificity of these effects on NPC proliferation support the critical modulatory effects of
neuroinflammation (Monje et al., 2003) and targeted effects of IL-1 and IL-6 signaling
(Monje et al., 2003; Spulber et al., 2008). Upon activation of microglia by
lipopolysaccharride (LPS) to release pro-inflammatory cytokines, a direct inhibition of NPC
proliferation has been observed (Cacci et al., 2005; Monje et al., 2003). In addition, this
inhibition is associated with an enhanced differentiation of NPC to the glial lineage. A
similar decline in NPC proliferation has been demonstrated in the hippocampus in vivo in
transgenic mice over-expressing IL-6 in astrocytes (Vallieres et al., 2002). Further
examination of the modulation effects of IL-1β showed that the inhibition of NPC
proliferation is the result of downstream signaling events occurring following the activation
of IL-1 receptor 1 (IL-1R1) (Koo and Duman, 2008). These effects of IL-1R1 activation
have not necessarily been translated in vivo in that transgenic mice over-expressing IL-1
receptor antagonist (IL-1Ra) demonstrated diminished NPC proliferation following an
excitotoxic injury (Spulber et al., 2008). The work of Spulber et al (2008) was the first to
suggest that the effect of IL-1R1 signaling on NPCs was conditional on the age of the
animal. Under non-injury conditions, the basal level of hippocampal NPC proliferation was
significantly diminished in 5 month-old IL-1Ra transgenic mice and by 22 months-of-age,
this difference was no longer evident.
Studies have demonstrated diminished hippocampal NPC proliferation as a function of aging
from the adolescent/young adult to the adult rodent (Hattiangady et al., 2008; He and Crews,
2007; Kuhn et al., 1996) and brain insult (Hattiangady et al., 2008; Shetty et al., 2010).
These studies clearly demonstrate an ontogeny in the level of hippocampal NPC
proliferation that has only been marginally examined within the framework of a coordinated
development of the proliferative SGZ, the dentate granule cell layer, and microglia. The
proliferative zone of the hippocampus is established between the 2nd and 4th week following
birth when precursor cells of dentate granule neurons populate the SGZ of the rodent
(Schlessinger et al., 1975). The dentate granule cell layer (GCL) is also established during
this same age period. Concurrent with these developmental processes, microglia are
proliferating rapidly and establishing a unique nervous system identity primarily between
postnatal days 5 to 20 (Lawson et al., 1990). The impact of these coordinated development
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events on the response of hippocampal NPC to injury and the associated elevation of pro-
inflammatory cytokines due to maturing microglia has not been adequately examined.
To address these questions, we compared changes in the SGZ in the adolescent (21 day-old)
and the adult (1 yr-old) CD-1 male mouse following a localized damage to the dentate
granule neurons. We utilized the hippocampal toxicant, trimethyltin (TMT) to produce
hippocampal damage, elevate pro-inflammatory cytokines, and induce the proliferation of
NPC within the SGZ (Harry and Lefebvre d’Hellencourt, 2003; Harry et al., 2004;
McPherson et al., 2010). Using this injury model, an elevation of IL-1α signaling via IL-1R1
and downstream genes within the IκB/NFkB1 signaling pathway were observed in the SGZ
of 21 day-old mice. An alternative pathway was activated in 1 yr-old mice, with an
upregulation of IL-6/gp130 signaling via the Ras/MAPK pathway. When we compared the
effects of IL-1α and IL-6 on the in vitro proliferation of NPCs obtained from the
hippocampus of adolescent and adult mice, a induction of NPC proliferation was observed
with IL-1α and a specific inhibition of NPC proliferation was seen in the 1 yr-old mice.
Thus, our data demonstrates an age-related shift in IL-1α and IL-6 signaling within the SGZ
supporting a differential effect of pro-inflammatory cytokines on hippocampal NPC self-
renewal following injury.
2. Materials and Methods
2.1. Animals
Male adolescent (21 day-old) and adult (1 yr-old) CD-1 mice were obtained from Charles
River Laboratories (Raleigh, NC). Mice were individually housed in a dual corridor, semi-
barrier animal facility with food (autoclaved NIH 31 rodent chow) and deionized, reverse
osmotic-treated water available ad libitum. Sentinel animals recorded negative for
pathogenic bacteria, mycoplasma, viruses, ectoparasites, and endoparasites. All procedures
were conducted in compliance with NIEHS/NIH Animal Care and Use Committee approved
animal protocol.
2.2. Model of dentate granule cell death
Mice received a single intraperitoneal (i.p.) injection of either 2.3 mg/kg trimethyltin
hydroxide (TMT; Alfa Products, Danvers, MA) or vehicle (saline), in a dosing volume of 2
ml/kg body weight using a 50 μL Hamilton syringe. Tremor was evident at 24 h post-TMT
with no acute morbidity. All endpoints were examined at 48 h post-dosing time point.
2.3. Tissue fixation and sectioning
Mice were anesthetized with CO2 and decapitated. Brains were excised, bisected in the
midsagittal plane, and one hemisphere immersion-fixed in 4% paraformaldehyde/0.1M
phosphate buffer (PB; pH 7.2) overnight at room temperature (RT). Within 24 h, the brains
were rinsed with PB and dehydrated in ethanol, embedded in paraffin, and sections were cut
at 8 μm. For unbiased stereology and immunostaining, mice from each treatment and age
group were deeply anesthetized by Nembutal (52 mg/kg, i.p.) at 48 h post-injection of saline
or TMT and perfused transcardially with 4°C 0.1 M phosphate buffer (PB) followed by 10
ml of 4°C 4% paraformaldehyde (PFA)/PB (ph 7.4). Brains post-fixed with 4% PFA/PB for
18 h, cryoprotected in 30% sucrose/PB, and frozen. Serial cryostat sections (≈70) were cut
at an instrument setting of 50 μm through the entire hippocampus. Based upon sampling
requirements for unbiased stereology, one section was selected from each block of 8
sections and stained for Nissl to visualize neuronal architecture.
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2.4. Histological assessment of neuronal death
From each mouse, six H&E stained sections at systematic-random location were selected
and the severity of dentate granule cell death scored by three independent observers
according to an a priori defined severity scale (0-4), as previously described (Harry et al.,
2008). Apoptotic cell death was detected with immunostaining for fractin, the product of
beta actin cleavage by active caspase 3 (Oo et al., 2002). Sections were incubated (72 h at
4°C) in 0.3% Triton X-100, 2% normal goat serum, and rabbit polyclonal antibody to fractin
(1:500; Invitrogen), rinsed, then incubated in 0.1M PB containing 0.3% Triton X-100, 2%
normal goat serum and AlexaFluor® goat anti-rabbit 594 (1:500; Invitrogen) for 30 min at
RT. Sections were coverslipped with ProLong Gold® with DAPI (Invitrogen). Digitized
images of were acquired using a Leica LSM 5 laser-scanning microscope.
2.5. Immunohistochemistry for microglia and astrocyte response
Cryostat sections were incubated (72 h at 4°C) in 0.3% Triton X-100, 2% normal goat
serum, and either rabbit polyclonal antibody to rabbit polyclonal anti-ionized calcium-
binding adaptor molecule 1 (Iba1 1:500; Wako Chemicals, Japan) or GFAP (1:500; Dako
Corp., Carpenteria, CA). Sections were washed, incubated in AlexaFluor® goat anti-rabbit
594 (1:500; Invitrogen) as described above. Sections were coverslipped with ProLong
Gold® with DAPI (Invitrogen) as a nuclear counterstain. Digitized images were acquired
using a Leica LSM 5 laser-scanning microscope.
2.6. Immunofluorescent staining and unbiased stereology of BrdU+ cells within the GCL/
SGZ
Mice, at both ages, were injected with 5-bromo-2′-deoxyuridine (BrdU [50 mg/kg i.p];
Sigma-Aldrich, St. Louis, MO) at the time of TMT or saline dosing, and four injections
thereafter every 12 h for 48 h allowing for incorporation at discrete intervals during the peak
interval of NPC proliferation. Based upon sampling requirements for unbiased stereology,
from the ~70 sagittal cryostat sections representing the entire hippocampus, a set of 8
sequential sections was sampled in a systemic-random manner, i.e., every eighth section
with a random start on sections 1-8. Sections were incubated at 37°C in 1N HCL for 30 min,
washed in PBS (30 min), and incubated in 0.1M PB with 0.3% Triton X-100, 2% normal
goat serum and rat monoclonal antibody to BrdU (1:500; Accurate Biochemicals; Westbury,
NY). Sections were washed, incubated in AlexaFluor® goat rat-488 (1:500; Invitrogen) as
previously described, and coverslipped with ProLong Gold® with DAPI. Digitized images
of immunofluorescence were acquired using a Leica DMBRE laser-scanning microscope.
To determine the number of newly generated BrdU+ cells, a fractionator, sampling scheme
for rare events was used (Kempermann et al., 2002). The sum of objects counted was
multiplied by the reciprocal of the fraction of reference space sampled. The sampling
fractions were defined as follows: (a) section sampling fraction (ssf), the number of sections
sampled divided by the total number of sections for each hippocampus; (b) area sampling
fraction (asf), the area of the sampling frame divided by the area of the x-y sampling step;
and (c) thickness sampling factor (tsf), the height of the dissector divided by the section
thickness. BrdU+ cells co-stained with DAPI were identified throughout the latero-medial
extension of the GCL and SGZ under 100× using a Leica DMRBE fluorescent microscope.
In this procedure, the uppermost and lowermost 5 μm focal planes of the section were
eliminated to avoid artifacts created by the knife blade. The number of BrdU+ cells was
estimated as N = ∑Q− (1/ssf)(1asf)(1tsf), where N = number of total estimated BrdU+ cells
and ∑Q− = the number of counted BrdU+ cells. All analysis was conducted with the
observer blinded to the treatment conditions.
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2.7. Confirmation of immature NPC phenotype in BrdU+ cells by nestin immunofluorescent
staining
A set of three sections was selected out of ~70 sagittal cryostat sections at random from
animals in each age and treatment group. Sections were immunostained for BrdU as
described with the addition of rabbit polyclonal anti-nestin (1:500; Abcam, Cambridge, MA)
as a marker for immature NPCs. Immunoreactive product was detected with AlexaFluor®
goat rat- 488 and AlexaFluor® goat rabbit-594 (1:500; Invitrogen) secondary antibodies.
Sections were coverslipped with Prolong Gold® with DAPI. Digital images were acquired
throughout the latero-medial extension of the GCL and SGZ under 60× magnification using
a Leica LSM 5 laser-scanning microscope. A series of 1 mm sections throughout the entire
z-plane was analyzed. To ensure that all nestin+ cells were captured regardless of location
within the hippocampal dentate, either the GGL or the SGZ, cells were counted across both
regions and data was expressed as the total number of BrdU+ cells co-expressing nestin.
2.8. qRT-PCR of hippocampal glial activation and pro-inflammatory cytokines
Total RNA was isolated from the hippocampus (n=6) using the RNeasy® Mini Kit (Qiagen,
Valencia, CA) and 2.5 μg used for reverse transcription (SuperScript™II Reverse
Transcriptase; Invitrogen). Quantitative real-time PCR (qRT-PCR) was carried out on a
Perkin Elmer ABI Prism™ 7700 Sequence Detector using 3 μl cDNA as a template,
combined with a reaction mixture to give final concentrations of 1X Power SYBR® Green
Master Mix (Applied Biosystems; Foster City, CA) and optimized forward and reverse
primers (Table 1). The 50 μl reaction mixtures were held at 50°C for 2 min, 95°C for 10
min, followed by 40 cycles at 95°C for 15 s, and 1 min at 60°C. Amplification curves from
individual qRT-PCR reactions were generated (Sequence Detection System (SDS) 1.9.1
software (Applied Biosystems)). Relative mRNA amounts were calculated using a
normalized standard curve and expressed as ratios of target gene to GAPDH.
2.9. Laser capture microdissection (LCM) of the SGZ
Cryostat sagittal brain sections (12 μm) were collected on uncoated glass slides and fixed for
1 min in 70% ethanol. Sections were rinsed in RNase-free water for 30 s, stained with
Histogene® Staining Solution (Arcturus, Mountain View, CA) for 15 s, rinsed in RNase-
free water for 30 s, dehydrated in 95% ethanol for 30 s, 100% ethanol for 30 s and xylene
for 5 min, and air-dried for 5 min in a laminar flow hood. A two-cell width at the inner-
blade edge of the GCL, representative of the SGZ, was excised using a PixCell Laser
Capture Microscope with an infrared diode laser (Arcturus) within 2 h of cryosectioning. A
total of 100 sections from each brain hemisphere provided 60000 μm2 × 100 total area from
the SGZ using 7500 laser pulses, 15 μm beam diameter, 75 mW power, 2.5 ms pulse. Total
RNA from LCM samples was isolated on an individual animal basis (n = 6) using the
PicoPure® RNA Isolation Kit (Arcturus) within 12 h of cyrosectioning. RNA on the column
was subjected to RNase-Free DNase Set (Qiagen) then eluted with Elution Buffer. qRT-PCR
was conducted as described for hippocampal tissues.
2.10. Generation of Primary Neurospheres
Two mm thick coronal sections containing the hippocampus were collected from three 21
day-old or 1 yr-old mice, as previously described (Bull and Bartlett, 2005). The
hippocampus was dissected from the coronal slice excluding the corpus callosum, lateral
ventricle, and cortex. Minced tissue was dissociated using the NeuroCult® Enzymatic
Dissociation Kit for Adult Mouse and Rat CNS Tissue (Stemcell Technologies, Vancouver,
BC). Single cell suspensions were sequentially filtered through 70 μm and 40 μm strainers
into proliferation medium (PM) consisting of mouse NeuroCult® NSC Basal Medium
(mouse) plus NeuroCult® NSC Proliferation Supplement (Stemcell Technologies) with the
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addition of 20 ng/mL recombinant human epidermal growth factor (rhEGF), 10 ng/mL
recombinant human fibroblast growth factor basic (rhFGFb), and 2 μg/mL heparin
(StemCell Technologies). Single cell suspensions were plated at a density of 3500 cells/cm2
in T-75 tissue culture flasks (BD Falcon) in PM, and incubated at 37°C in 5% CO2/5% O2,
forming neurospheres by 7 days in vitro (DIV).
2.10.1. Neural colony forming-cell assay (NCFCA)—The NeuroCult® Neural
Colony-Forming Cell Assay Kit (NCFCA; StemCell Technologies) was used to discriminate
between stem and progenitor cells on the basis of their proliferative capability and size of
colony formed. At 7 DIV, neurospheres generated from the hippocampus of each age and
each dosing group were dissociated into single cell suspensions (NeuroCult® Chemical
Dissociation Kit; StemCell Technologies) for use in NCFCA as previously described (Louis
et al., 2008). Briefly 2.5 × 103 cells were plated in 35 mm tissue culture dishes in a semi-
solid collagen matrix containing NeuroCult® NCFC media, supplemented with 20 ng/ml
rhEGF, 10 ng/ml rhFGFb and 2 μg/ml heparin. Cultures were incubated at 37°C in 5%
CO2/5% O2 and fed with 60 μl of PM every 7 days, until 21 days. At 21 days post-plating,
the total number of colonies was counted from each experimental group, and categorized by
size, as imaged by an inverted Nikon TE-2000 microscope using a 2 mm × 2 mm gridded
scoring dish (StemCell Technologies).
2.10.2. qRT-PCR for IL-1R1, IL-1RAcP, IL-6Rα, gp130 in neurospheres—To
measure mRNA expression, total RNA was isolated from neurospheres at 7 DIV (RNeasy®
Mini Kit; Qiagen). qRT-PCR for each transcript (Table 1) was conducted as described for
hippocampal samples. Amplification curves were generated and relative mRNA amounts
were calculated using a normalized standard curve and expressed as ratio of target gene to
GAPDH.
2.11. NCFCA in the presence of IL-1α or IL-6
The NCFCA was used to determine the effects of IL-1α or IL-6 on the formation of neural
cell colonies. Based upon previous work (Harry et al., 2002; Monje et al., 2003) a dose
range of recombinant IL1α and IL-6 was selected. At initial plating of single cell
suspensions, media (NeuroCult® NCFC Serum Free Media without Cytokines; 20 ng/ml
rhEGF, 10 ng/ml rhFGFb and 2 μg/ml heparin) was supplemented with either recombinant
mouse IL-6 (rmIL-6, [5, 10, or 15 ng/ml]) or recombinant mouse IL-1α (rmIL-1α [75, 150,
or 150 pg/ml]) (R&D Systems; Chicago, IL). In NPCs obtained from adolescent
hippocampus, a linear dose response pattern was evident with a stimulation of proliferation
observed with IL-1α and an inhibition with IL-6 (Suppl. Fig. 1). From this dose response,
dose levels of IL-1α (150 pg/ml) and IL-6 (10ng/ml) were selected for a direct comparison
of proliferation across age of NPCs. An additional comparison was conducted with a
combined dosing of rm IL-6 [10 ng/ml and rm IL-1α [150 ng/ml]. Cells were incubated at
37°C in 5% CO2/5% O2. Cultures were fed with 60 μl of PM every 7 days until 21 days. At
21 days post-plating, the total number of colonies was counted from each experimental
group, and categorized by size.
2.12. Statistical analysis
Data for cell number determination and each mRNA transcript displaying a homogenous
distribution of variance were analyzed by ANOVA. Group differences between 21 day-old
and 1 year-old mice with and without TMT were assessed using a 2 × 2 multi-factorial
ANOVA with age and treatment as major factors. Subsequent independent group mean
comparisons were conducted using the Bonferroni test. Student t-tests were conducted to
determine the effect of combined cytokine exposure and mRNA levels within NPCs
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obtained from control mice at each age. All statistical significance levels for independent
group mean analyses were set at p < 0.05.
2.13. Microarray analysis
To examine changes induced in genes related to the IL-1 and IL-6 pathways, total
RNA(10-20 ng) from LCM samples of the SGZ (n=3) was amplified (Affymetrix One-Cycle
cDNA Synthesis Protocol). Fifteen μg of amplified biotin-cRNAs were fragmented and
hybridized to Affymetrix Mouse Genome 430 2.0 GeneChip® array for 16 h at 45°C in a
rotating hybridization oven using the Affymetrix Eukaryotic Target. Slides were stained
with steptavidin/phycoerythrin using a double-antibody staining procedure and washed
utilizing the EukGE-WS2v5 protocol of the Affymetrix Fluidics Station FS450 for antibody
amplification. Arrays were scanned with an Affymetrix Scanner 3000 and data obtained
using the GeneChip® Operating Software (GCOS; Version 1.2.0.037). Data were processed
with an Affymetrix-specific error model for estimating measurement variance, using Rosetta
Resolver, as described (Weng et al., 2006). Biological replicates were combined through
error-weighted averaging and comparison ratios were built between samples. Statistical
significance was set at p<0.001 and a minimum fold change of 1.2 was set as criteria.
Genes that were differentially regulated in 21 day-old versus 1 yr-old TMT exposed mice,
taking into account differences in baseline expression in naïve mice, were analyzed using
PathwayArchitect (Stratagene) software. This software uses the KEGG, DIP, and BIND
databases and natural language scans of Medline to identify functional associations among
differentially expressed genes. Gene interactions and associations (binding, expression,
metabolism, promoter binding, protein modification and regulation) were represented
graphically as a network. In this analysis, age was considered a mediator of injury related
differential expression patterns using ANOVA.
3. Results
3.1. TMT induced an equivalent level of localized dentate granule neuron apoptosis at 21
days and 1 yr of age
We examined severity of neuronal apoptosis in the GCL and determined a uniform level and
timing of hippocampal neuronal death induced by TMT across both ages. No evidence of
cell death was observed by H&E staining in saline treated control (severity scores = 0-1;
Fig. 1A,B). At 48 h post-TMT, dentate granule neurons displayed nuclear pyknosis and
karyolysis (severity scores = 3-4; Fig. 1C,D). No indication of apoptosis was detected in
saline control mice by immunostaining for fractin (Fig. 1E,F); fractin+ neurons were
prominent following TMT (Fig. 1G,H).
3.2. TMT injury-induced proliferation is greater in the adolescent versus mature
hippocampus
In the 21 day-old and 1 yr-old control mice, BrdU+ cells were sparse and restricted to the
GCL inner blade/SGZ (Fig. 2A,B). An increase in BrdU+ cells was observed at 48 h post-
TMT in the SGZ, as well as within the GCL in both 21 day-old (Fig. 2C) and the 1 yr-old
mice (Fig. 2D). These visual observations were confirmed by unbiased stereology (Fig. 2E).
Two-way ANOVA revealed a significant effect of treatment (F(1,8)=49.58; p=0.0001), age
(F(1,8)=43.43; p=0.0002), and treatment × age interaction on BrdU+ cell number in the GCL/
SGZ (F(1,8)=27.20; p=0.0008). The number of BrdU+ cells within the GCL/SGZ was
significantly higher in the 21 day-old control mice than in 1 yr-old control mice (p<0.05). In
both age groups, TMT exposure resulted in a significant increase in the number of BrdU+
cells within the GCL/SGZ (p<0.05). In 21 day-old mice, the increase in BrdU+ cells was
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approximately 7-fold higher than the basal level observed in controls. In 1 yr-old mice, the
increase in BrdU+ cells was significantly less, at an estimated 3.5-fold elevation (p<0.05).
We then confirmed the proliferation of NPC by examining immunostaining for nestin and
co-localization with BrdU (Fig. 2F-H). To capture any changes in the distribution of NPCs
as a function age or injury, the distribution of BrdU+ cells across the entire GCL was
examined. The percent total #BrdU+ cells throughout the GCL that co-expressed nestin was
determined within controls and TMT-dosed mice for each age group (Fig. 2I). A two-way
ANOVA indicated a significant main effect of age (F(1,8)=36.41; p=0.0003) with the 21 day-
old mice showing a higher percentage of co-localized immunostaining as compared to 1 yr-
old, across both conditions. A significant main effect of TMT treatment (F(1,8)=49.04;
p=0.0001) was observed with an increase in co-localization at 48 h following TMT
injection. No significant interaction of age and TMT was detected with the adolescent mice
showing an approximate 30% increase over the higher basal level and the mature mice
demonstrating an approximate 50% increase over the lower basal level.
3.3. Microglia demonstrate different morphological responses to injury as a function of
age
In the normal 21 day-old mouse hippocampus, microglia displayed thin, ramified processes
within the SGZ, hilus, and the densely packed dentate GCL (Fig 3A). Similar to the Iba-1
staining pattern in the 21 day-old, microglia within the 1 yr-old hippocampus were
prominent within the hilus and molecular layer. In addition, Iba-1+ microglia displayed an
increased staining in processes within the SGZ, hilus, and GCL (Fig. 3B), suggestive of a
lower threshold for activation (Sparkman and Johnson, 2008).
In the 21 day-old mice, neuronal injury and loss following TMT induced an activation of
microglia displaying an amoeboid morphology within proximity to dying neurons showing
dense collapsed nuclei (Fig. 3C). In addition, process-bearing responsive microglia were
evident throughout the GCL and in the hilus, occasionally extending into the SGZ. In 1 yr-
old mice, a comparable level of neuronal death did not result in the localization of amoeboid
microglia with dying neurons. Rather, prominent reactive microglia within the GCL
displayed thick ramified processes. Similar to the 21 day-old mice, process-bearing reactive
microglia were observed throughout the GCL and hilus occasionally extending into the SGZ
(Fig. 3D). The morphological response of microglia was supported by qRT-PCR of Iba-1
(Fig. 3E). Two-way ANOVA of Iba-1 mRNA levels revealed a significant effect of
treatment (F(1,20)=8.438; p<0.0088) and higher levels seen in the 21 day-old TMT dosed
mice. (p<0.05). No significant main effects of age or interaction between age and treatment
were observed.
3.4. GFAP+ astrocytes demonstrate similar morphological responses to injury across ages
In control mice, minimal differences in GFAP staining were observed as a function of age.
At both ages, astrocytes displayed fibrous processes projecting thorough the SGZ and GCL
(Fig. 3F,G). Within 48 h post-TMT a retraction and moderate thickening of GFAP
processes, was evident throughout the GCL (Fig. 3H,I). The increase in GFAP
immunoreactivity with TMT was supported by qRT-PCR for GFAP mRNA levels (Fig. 3J).
Two-way ANOVA revealed a significant effect of treatment (F(1,20)=14.82; p=0.001) with a
significant increase observed following TMT in both ages, as compared to controls (p<0.05).
No significant main effects of age or age × treatment interaction were observed.
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3.5. IL-1α and IL-6 mRNA levels are differentially elevated in the hippocampus following
TMT as a function of age
Given the differential activation of microglia in 21 day-old, as compared to 1 yr-old mice,
additional characterization of the microglial response was conducted based on proposed pro-
inflammatory (MI) or anti-inflammatory (M2) phenotypes (Colton and Wilcock, 2010;
Michelucci et al., 2009). Gene expression associated with the M1 phenotype was examined
(IL-1β, IL-6) as well as the pro-inflammatory cytokine IL-1α. Expression of anti-
inflammatory M2 phenotype associated genes: arginase I (AG-I), chitinase 3-like-3 (YM-1),
IL-10, and transforming growth factor beta (TGFβ1) were also examined. Consistent with
our previous work (Bruccoleri et al., 1998), we did not observe an elevation in mRNA levels
for TGFβ1 in the hippocampus at this early time point (Fig. 4A). IL-10 and AG-I mRNA
levels were not significantly altered in the hippocampus (Fig. 4A) following TMT. No signal
for YM-1 mRNA was detected (data not shown). IL-1β mRNA expression was not
significantly elevated by TMT in either age group (Fig. 4A). Two-way ANOVA for IL-1α
mRNA expression showed significant main effects of treatment (F(1,20)=45.41; p=<0.0001),
age (F(1,20)=19.91; p<0.0001), and treatment × age interaction (F(1,20)=24.67; p=<0.0001).
A significant TMT-induced elevation was observed in 21 day-old mice (p<0.001). IL-6
mRNA levels in the hippocampus were significantly elevated following TMT
(F(1,20)=7.755; p=<0.05) in 1 yr-old mice (p<0.001).
3.6. TMT-induced injury selectively elevated IL-6 mRNA in SGZ of mature mice
To further examine whether the differential inflammatory cytokine response observed in the
hippocampus was observed within the SGZ, mRNA levels were determined from LCM
samples. A slight elevation in mRNA levels for TGFβ1 within the SGZ following TMT was
noted at both ages but failed to reach statistical significance (Fig. 4B). IL-10 and AG-I
mRNA levels in the SGZ were not significantly altered by TMT (Fig. 4B). No signal for
YM-1 mRNA was detected (data not shown). mRNA levels for IL-1β showed no significant
differences as a function of age or TMT injection (Fig. 4B). IL-1α mRNA levels (Fig. 4B)
were significantly elevated with TMT (F(1,20)=42.50; p<0.0001) in both age groups
(p<0.01). No significant effect was observed as a function of age. IL-6 mRNA levels (Fig.
4B) were significantly elevated by TMT (F(1,20)=8.595; p<0.005) and with age
(F(1,20)=5.304; p<0.05). A significant treatment × age interaction (F(1,20)=5.036; p<0.05)
was detected with TMT-induced elevations in IL-6 mRNA levels occurring in 1 yr-old mice
(p<0.05).
3.7. In vivo TMT exposure induced neural colony cell formation in vitro
Neurogenic cells within the SGZ are primarily progenitor cells that maintain the capability
to differentiate into neurons or glia (Bull and Bartlett, 2005; Seaberg and van der Kooy,
2002); however, with localized neuronal activation, a latent stem cell population has also
been identified (Walker et al., 2008). Using the NCFCA to discriminate between colonies of
neural stem and progenitor cells, we examined alterations in the size of colonies formed
from hippocampal cells as a function of age and in vivo neuronal activation/injury by TMT.
We found no difference in culturing success of NPC from young and mature brains,
consistent with similar published work (Blackmore et al., 2009). Colonies >2.0 mm were not
observed in either age or treatment group, suggesting origination from progenitor cells,
rather than stem cells. The mean total number of colonies generated in vitro was greater in
21 day-old as compared to the 1 yr-old saline control mice (Fig. 5A; p<0.005). TMT
treatment induced colony formation from both 21 day-old and 1 yr-old mice. The number of
colonies generated from the hippocampus of mice injected with TMT was greater at 21 days
of age compared to the 1 yr-old; however, the fold increase over saline control was similar
in both ages (1.8 fold for 21 day-old and 1.9 fold for the 1 yr-old).
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3.8. NPCs from the adolescent and mature hippocampus express IL-1R1, IL-1RAcP, IL-6Rα,
and gp130
To confirm that NPC displayed the capability to respond to the in vivo elevations in IL-1α
and IL-6 within the SGZ, IL-1R1, IL-1RAcP, IL-6Rα, and gp130 mRNA levels were
determined in isolated NPCs generated from each age group. A basal level of each transcript
was detected (Fig. 5D). No differences as a function of age were seen for IL-1R1,
IL-1RAcP, or gp130. Hippocampal NPCs derived from 1 year-old mice expressed higher
levels of IL-6Rα, compared to NPCs from 21 day-old mice (t = 4.871, p < 0.05).
3.9. IL-1α stimulated colony formation of adolescent NPCs and IL-6 inhibited colony
formation of adolescent and mature NPCs
Given the expression of IL-1 and IL-6 receptors on NPCs, we examined the proliferative
response to exogenous recombinant IL-1α, IL-6, or a combination of IL-1α and IL-6
proteins in the NCFCA. Following a 21 DIV exposure to rmIL-1α, two-way ANOVA
revealed a significant effect of treatment (F(1,8)=14.64; p=0.005), age (F(1,8)=127.3;
p=<0.0001), and treatment × age interaction on total colony formation (F(1,8)=7.029;
p=0.02). Treatment with rmIL-1α significantly increased formation of colonies obtained
from the hippocampus of 21 day-old mice (p<0.05; Fig. 6A). rmIL-1α did not stimulate
colony proliferation in cultures obtained from the hippocampus of 1 yr-old mice. Following
21 DIV, exposure to rmIL-6 produced a significant effect of treatment (F(1,8)=14.64;
p=0.005), age (F(1,8)=127.3; p=<0.0001), and treatment × age interaction on total colony
formation (F(1,8)=7.029; p=0.02). Decreased colony formation with rmIL-6 was observed in
hippocampal NPC from both ages (p<0.05; Fig. 6B). In NPCs from 21 day-old mice,
concurrent exposure to IL-1α and IL-6 did not result in a significant increase in colony
formation thus, inhibiting the stimulatory properties of IL-1α. (Fig. 6C) In NPCs from 1-yr-
old mice, concurrent exposure to both cytokines resulted in a significant decrease (t=3.113,
p<0.05) in colony formation similar to the effects observed with IL-6 alone.
3.10. Differential activation of the IL-1 pathway in the adolescent and the IL-6 pathway in
the mature SGZ following TMT injury
Based upon our observations that hippocampal NPCs isolated from both age groups 1)
expressed IL-1 and IL-6 receptors for downstream signaling activation, 2) expressed both
cytokines in vivo within the SGZ, and 3) demonstrated age related proliferative responses in
isolated NPC, we examined the molecular profiles associated with both receptor pathways as
a function of age and injury. Microarray profiles generated from LCM SGZ tissue identified
a total of 109 unique transcripts changed in the 21 day-old samples, 54 unique transcripts in
the 1 yr-old samples, with a total of 88 similarly changed at both ages as a function of TMT
(Fig. 7A). While a full analysis of the microarray data is outside the scope of this
manuscript, a number of genes were identified in support of the speculation that a greater
level of “immune” activation occurs in the adolescent SGZ. For example, CD44 antigen
transcript was elevated 10.9-fold (p<0.0001) in the adolescent with only a 2-fold (p=0.23)
elevation in the adult. Similar patterns were seen for Mmd (monocytes to macrophage
differentiation-associated) transcripts with a 2.8-fold increase in the adolescent (p<0.00001)
and a 1.4 fold increase in the adult (p=0.0005) and for Msr2 (macrophage scavenger
receptor 2) with a 3.4-fold increase (p<0.000001) in the adolescent and a 1.08-fold non-
significant increase in the adult.
We used PathwayArchitect software to examine the differential expression of IL-1α and
IL-6 related genes in the SGZ as a function of age and TMT injury. The transcript
expression pattern generated from the SGZ suggested a primary involvement with injury of
the IL-1 signaling pathway in the 21 day-old mice with IL-6 serving a primary role in the
SGZ of 1 yr-old mice (Fig. 7B). Using this approach, statistical significance was set at
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p<0.001 and a minimum fold change of 1.2 was set as criteria. IL-1α and IL-1R1 were
induced at a greater level in the adolescent SGZ compared with the mature SGZ. A specific
alternative pathway for neurogenesis has yet to be reported. We now report a network
association between IL-1α and signaling genes downstream of IL-1R1 including: myeloid
differentiation primary response gene-88 (Myd88), IκB, and NFκB1 in the SGZ with higher
levels in the 21 day-old injured SGZ as compared to the 1 yr-old mice.
With TMT injury, IL-6 mRNA levels were significantly elevated in the SGZ of 1 yr-old
with a minimal induction in 21 day-old mice. The IL-6/IL-6R complex initiates signaling
through the gp130 receptor (Jones et al., 2005) leading to activation of either Janus kinase
(JAK) or Ras-mediated signaling (Heinrich et al., 1998; Hirano et al., 2000) regulating cell
growth, proliferation, differentiation, and apoptosis. We noted a concurrent upregulation of
IL-6 and a number of Ras-mediated signaling genes in the SGZ of adult mice following
injury. Ras-Genes elevated in the Ras/MAPK signaling pathway included SHC, the gene
encoding a signaling and transforming protein Src homology 2 and 3 that are involved in
mitogenic signal transduction and facility the activation of Ras proteins. Growth factor
receptor bound protein-2 (Grb-2), an adaptor protein involved in epidermal growth factor
receptor tyrosine kinase for the activation of Ras and downstream kinases, ERK1,2.
Elevations were noted in v-raf-1, murine leukemia viral oncogene homolog 1 (Raf-1), the
gene encoding MAP3K that functions downstream of Ras membrane associated GTPases.
Raf-1 phosphorylates MEK1 and MEK2 to activate ERK1 and ERK2, controlling gene
expression involved in cell division, differentiation, migration, and apoptosis. Elevations
were seen in mitogen-activate protein kinase kinase-1 (MAP2K1) for which the associated
protein product, MEK1 protein kinase is essential for normal development before and
survival after birth.
4. Discussion
In the current study, we examined microglia activation, IL-1α and IL-6 mRNA levels, and
NPC proliferation within the SGZ in mice exposed to the hippocampal toxicant, TMT.
Based upon the adolescent establishment of the proliferative SGZ (Schlessinger et al., 1975)
and active NPC proliferation in the hippocampus, we further compared differences in the
response to TMT-induced injury as a function of age. These comparisons incorporated
differences in the SGZ of the normal adolescent hippocampus as compared to an adult age
showing a decline in NPC proliferation. Our data confirmed previous reports of a greater
number of NPCs in the SGZ of adolescent, as compared to adult mice under normal
conditions (Ben Abdallah et al., 2010; He and Crews, 2007; Kuhn et al., 1996), as well as
with brain injury (Hattiangady et al., 2008; Shetty et al., 2010). The novel findings of these
studies include age-related differences in the response of isolated NPCs to IL-1α or IL-6 and
the molecular profiles generated from the injured SGZ. First, we report that the age-related
level of NPC proliferation in vivo following TMT-induced injury correlates with elevations
in IL-1α mRNA levels in the adolescent hippocampus and IL-6 within the adult. We show
that proliferation of NPCs isolated from the hippocampus of mice at both ages was inhibited
by IL-6. Proliferation of NPCs by IL-1α was observed only in cells derived from the
hippocampus of adolescent mice and not from NPCs from the mature hippocampus. Third,
we examined the molecular profile of the SGZ from each age and treatment and identified
distinct signaling pathway activations as a function of age. TMT injury selectively induced
an activation of IL-1α signaling via IL-1R1 and downstream genes within the IkB/NFkB1
signaling pathway in the 21 day-old and IL-6Rα/gp130 signaling via the Ras/MAPK
pathway in the 1 yr-old mice. From these data, we conclude that the age related expression
of IL-1α and subsequent signaling pathway activation in the adolescent fosters NPC
proliferation. In comparison, activation of the IL-6Rα/gp130 pathway in the adult
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contributes to maintaining a tight regulatory control on NPC proliferation, thus serves as a
basis for an age-dependent level of NPC self-renewal following injury.
Both IL-1β and IL-α induce signaling via binding to IL-R1 followed by a sequence of
protein-protein interactions forming a complex to recruit IL-1RAcP (Greenfeder et al.,
1995). Myeloid differentiation primary response gene-88 (Myd88) is then recruited to the
IL-1α/IL-R1 complex activating the interleukin-1 receptor associated kinase (IRAK)
(Wesche et al., 1997), for activation either of ERK, p38MAPK, c-jun, or NFκB signaling
(Dunne and O’Neill, 2003; O’Neill, 2002; O’Neill and Greene, 1998). Previous studies have
demonstrated that IL-1R1 is expressed in vitro in NPCs isolated from the rat embryonic
forebrain (Wang et al., 2007) and in the adult rat hippocampus in vivo (Koo and Duman,
2008). This receptor expression suggests the potential for direct effect of receptor action via
IL-1β or IL-1α (Greenfeder et al., 1995). Wang et al., (2007) demonstrated that the treatment
of rat embryonic forebrain NPCs with IL-1β and upon IL1-R1 activation of the SAP/JNK
pathway inhibited proliferation. Additionally, activation of the NFκB pathway by IL-1β
binding to IL-1R1 decreased proliferation but not differentiation of adult hippocampal NPCs
both in vivo and in vitro (Koo and Duman, 2008). Inhibition of proliferation, observed by
Wang et al. (2007), was accompanied by a normal pattern of cell differentiation; but a lower
level of GFAP protein expression in differentiated NPCs. A direct effect of IL-1β on the
differentiation of NPCs to neurons has been suggested by the work of Kuzumaki et al.,
(2010) indicating a decrease in β-tubulin+ neurons differentiated from mouse whole brain
embryonic NPCs.
While the majority of the work on IL-1 signaling in NPCs has focused on IL-1β, IL-1α also
activates the IL-1R1 and direct effects on NPCs have been observed. Using mouse
embryonic cortical NPCs, IL-1α exposure was reported to direct differentiation to the
astrocyte lineage (Ajmone-Cat et al., 2010). The effect of IL-1R1 signaling on NPC
proliferation has been supported by the studies of Spulber et al. (2008) utilizing transgenic
mice overexpressing IL-1 receptor antagonist (IL-1ra). In these animals, the overexpression
of IL-1ra was sufficient to inhibit in vivo excitotoxicity-induced hippocampal progenitor cell
proliferation. Further observations from this study suggested that the effect of IL-1ra on the
in vivo basal level of hippocampal progenitor cell proliferation was influenced by the age of
the animal. In 5 month-old mice, the IL-1ra transgenic mice demonstrated a decrease in
basal proliferation for which no such effects were observed in mice at ~22 months of age.
Our current data supports the work of Spulber et al. (2008) suggesting that the effect of
IL-1R1 activation on NPCs can be dependent upon the age of the animal. In the isolated
SGZ, a significant elevation was observed for IL-1α in both age groups; however, activation
of the IkB/NFkB signaling cascade was restricted to the adolescent. Consistent with this in
vivo observation, IL-1α stimulated in vitro proliferation of NPCs isolated from adolescent
hippocampus; while, no such effects were observed in cells isolated from the adult.
Activated microglia provide the earliest source of IL-1α and IL-1ra after injury (Eriksson et
al., 2000; Eriksson et al., 1999) and in the TMT-induced injury model (Bruccoleri et al.,
1998). Thus, the age related changes we observed in the current study with regards to
IL-1R1 activation are likely influenced by the maturation of microglia and differences in
activation. Just as the functional capability of microglia change in the aged brain (Streit,
2006), microglia during the postnatal period represent a more immature phenotype
(Kuzumaki et al., 2010; Rezaie and Male, 1999; Yokoyama et al., 2004). TMT induced a
similar severity of neuronal death in both age groups but a pronounced activation of
microglia within the GCL was seen only in the adolescent, as evidenced by the
morphological phenotype and the elevation in IL-1α. In the adult, a more blunted
hypertrophic process-bearing microglia response was observed. No elevation was observed
the in microglia M2 associated genes, AG-I, TGFβ1, IL-10, and chitinase-3-like-3 (YM-1)
(Colton and Wilcock, 2010; Michelucci et al., 2009) suggesting the absence of an
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alternatively activated microglia phenotype at both ages following TMT exposure. Thus, as
a source of IL-1α in this injury model (Bruccoleri et al., 1998), activated microglia could
serve as a major influence not only on the NPC in vivo but also on the surrounding
astrocytes, resulting in an environment promoting differences observed as a function of age.
The prominent cytokine response observed in the adult GCL and SGZ following TMT-
induced injury was the up-regulation of IL-6. We also showed a slight elevation in mRNA
levels of IL-6 in the normal adult hippocampus as compared to the adolescent. This finding
is consistent with the report of an increase in IL-6 protein expression in the hippocampus of
aged, as compared to juvenile mice (Ye and Johnson, 1999,2001). While a body of literature
exists demonstrating the ability of multiple neural cell types to express IL-6 mRNA or
protein, there is limited available data in the literature demonstrating the cellular source of
IL-6 within the brain. Recent work suggests the expression of IL-6 protein in cortical lesions
from patients with either tuberous sclerosis complex (TSC) or focal cortical dysplasia type
IIb (FCDIIb)(Shu et al., 2010). Within the TSC tubers cortical tubers, IL-6
immunoreactivity co-localized to dysmorphic neurons and giant neurons with no evidence of
localization to GFAP astrocytes. In FCDIIb, balloon cells expressed both IL-6 and GFAP.
Additional work suggests the expression of IL-6 in neurons of the cerebral cortex and
hypothalamus with trinitrobenzene sulfonic acid-induced colitis (Wang et al., 2010). Further
work has demonstrated that the combination of neuronal depolarization and activation of
IL-1R1 with IL-1β can induce neurons to synthesize and release IL-6 (Juttler et al.,
2002;Ringheim et al., 1995; Tsakiri et al., 2008a,b). It is possible that the production of
IL-1α by microglia, coinciding with the stimulation of neurons by TMT, could lead to the
increased neuronal production of IL-6. Microglial production of IL-6 has also been
demonstrated in non-pathological conditions in vivo (Schobitz et al., 1992) and classically
activated M1 microglia are also identified to produce IL-6 (Colton and Wilcock,
2010;Monje et al., 2003). We attempted to identify the cellular source of IL-6 within the
current study however, a consistent staining pattern was not observed across various
antibody sources. With a monoclonal antibody we were able to identify localization to
neurons; yet, with a polyclonal antibody, a similar pattern of neuronal expression was
lacking and the overall impression was of localization to microglia. In neither case did we
identify immunoreactivity within GFAP+ astrocytes. However, to identify the cellular
source will require additional studies to verify specificity of the antibodies and confirmation
of a consistent pattern of immunostaining. Whatever the source, the effects of IL-6 upon
NPCs were clearly demonstrated.
IL-6 binds to IL-6Rα then to the gp130 receptor to initiate signal transduction via the Janus
tyrosine kinase /signal transducers and activators of transcription 3 (JAK/STAT3) and
phosphatidylinositol (PI)-3 kinase/Akt pathways. It is known that these pathways can then
be employed as a mechanism for cell survival (Reich, 2007). Recent studies report that,
while rat embryonic neural stem cells respond in vitro to IL-6 (Nakanishi et al., 2007), NPCs
from the embryonic subventricular zone (SVZ) do not express a functional membrane IL-6R
(Islam et al., 2009). In this latter case, exposure to hyper IL-6 (the complex of IL-6/IL-6R)
was required to stimulate gp130 signaling and cell differentiation (Islam et al., 2009). IL-6
has been shown to promote astrocytic differentiation of embryonic neural stem cells derived
from the rat SVZ (Nakanishi et al., 2007) via the Janus tyrosine kinase/signal transducers
and activators of transcription 3 (JAK/STAT3) signaling pathway (Bromberg and Darnell,
2000). Monje et al., (2003) reported that, in vitro, IL-6 inhibits neuronal differentiation of
adult hippocampal NPCs; however, recent work demonstrated that while gliogenesis due to
IL-6 receptor activation is related to signaling via the JAK/STAT pathway, neuronal
differentiation occurs via activation of the RAS-MAPK signaling pathway (Islam et al.,
2009; Taga and Fukuda, 2005). Within the SGZ of the adult brain, we now report elevations
in genes associated with both IL-6Rα and gp130, as well as genes associated with
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downstream signaling through Ras to activate Raf-1 or MAP2K1. The prevailing hypothesis
that acute exposure to IL-6 is detrimental to NPCs (Ekdahl et al., 2003; Ekdahl et al., 2009;
Monje et al., 2003; Vallieres et al., 2002), is further supported by our finding that IL-6
inhibited proliferation of hippocampal NPCs, regardless of age. While the inhibition of
proliferation may be a direct effect, further studies may determine a correlation with an
earlier onset of differentiation. In light of the work of Islam et al. (2009), a possible role for
IL-6 in promoting neurogenesis for replacement of dentate granule cells following
hippocampal injury with TMT requires consideration.
In the early work identifying the sustained neuro-proliferative capability of the
hippocampus, Altman et al., (1973) proposed the idea that changes occurring with
maturation from the adolescent to the adult hippocampus represented selective stabilization
of the structure. Consistent with this idea, and similar ones proposed by Changeux and
Dauchin (1976), is the idea that the higher levels of NPC proliferation observed in the
adolescent brain reflect a greater level of hippocampal plasticity. Lower levels observed in
the adult appear to reflect a system focused on maintaining cellular homeostasis and
survival. We now propose that the contribution of pro-inflammatory cytokines, and possibly
neuroinflammation in general, varies as a function of maturational stage and can assume
different regulatory roles with regards to the self-renewal of NPCs within the injured
hippocampus. One could speculate that the upregulation of IL-1α, as an initiator, and the
lack of corresponding upregulation of IL-6, as a down-regulator, serve to enhance the
neurogenic proliferative response to injury in the adolescent SGZ. In comparison, in the
adult hippocampus, the GCL is a more developed and compacted region and the induction of
IL-6 and absence of IL-1 signaling with injury may represent these maturational differences.
The dynamic neurogenic response in the adolescent hippocampus following the death of
dentate granule neurons as a result of a systemic injection of TMT provides a model to
identify critical factors delineating the adolescent SGZ and the transition to an adult profile.
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(A-D) Representative hematoxylin and eosin (H&E) staining in the subgranular zone (SGZ)
and granule cell layer (GCL) of the dentate gyrus (DG) in CD-1 male mice. Twenty one
day-old (A) and 1 yr-old (B) saline control, or 21 day-old (C) and 1 yr-old (B) at 48 h post-
TMT (2.3 mg/kg i.p.). (C & D) Eosin+ staining (deep pink) of neurons displaying nuclear
pyknosis and karyolysis indicated an equivalent level of neuronal death (represented by a
severity score of 3-4 as defined in Methods). (E-H) Representative immunofluorescent
staining for fractin (red; arrowheads) and DAPI (blue) in the GCL. Scale bar = 50 μm.
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(A-D) Representative immunofluorescent images of 5′-bromo-2′-deoxyuridine (BrdU)
(green) and DAPI (blue) in the SGZ and GCL (A, B) along the inner cell layer of saline
control mice and (C, D) within the GCL 48 h post- TMT (2.3 mg/kg i.p.). Scale bar = 50
μm. (E) Unbiased stereology of the number of BrdU+ determined by rare events protocol as
described in Methods. Data represents mean ± SEM as defined in Methods and analyzed by
a 2×2 ANOVA followed Bonferonni post hoc test (*p < 0.05). (F-H) Representative
immunostaining of BrdU+ cells co-localized with nestin at 48 h post-TMT. Scale bar = 10
μm (I) Mean + SEM number of BrdU+ cells that co-stained with nestin within the SGZ and
GCL. Data analyzed by a 2×2 ANOVA followed by Bonferonni post hoc test (*p < 0.05).
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Representative images of Iba-1+ microglia (A-D, red) and GFAP+ astrocytes (F-I, red),
DAPI (A-D, F-I, blue), in the GCL and SGZ (lower portion of each image) in saline control
and 48 h post-TMT CD-1 male 21 day-old or 1 yr-old mice. (A) Iba-1+ cells in control 21
day-old mice showed thin elongated processes with distal ramifications. (B) Iba-1+ cells
(red) in 1 yr-old mice showed increased staining thickened processes with proximal
arborization. With TMT (C) Iba-1+ cells differentiated to a rounded amoeboid morphology
in the GCL and cells with enlarged cell bodies and retracted processes in the hilus in the 21
day-old and (D) process bearing cells showing thickened and retracted processes in the 1 yr-
old. (F-I) GFAP+ astrocytes (red) showing thin processes through the GCL in (F, G) control
and an increased staining at 48 h post-TMT in both (H) 21 day-old and 1 yr-old (I). Scale
bar = 50 μm. (E, J) qRT-PCR mRNA levels for Iba-1 and GFAP relative to GAPDH. (E)
mRNA levels for Iba-1 were significantly elevated in the 21 day-old at 48 h post-TMT. (J)
mRNA levels for GFAP were significantly elevated in the 21 day-old and 1 yr-old mice 48 h
post-TMT. Data represents mean ± SEM. Data analyzed by a 2×2 ANOVA followed by
Bonferonni post hoc test (*p<0.05).
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qRT-PCR mRNA levels of TGFβ1, IL-10, AG-I, IL-1β, IL-α, and IL-6 in the (A)
hippocampus and (B) laser-capture microdissected subgranular zone (SGZ) of 21 day-old
and 1 yr-old saline and TMT treated mice at 48 h post-TMT (2.3 mg/kg, i.p.). Data
represents mean ± SEM mRNA expression relative to GAPDH (n=6) analyzed by a 2×2
ANOVA followed by Bonferonni post hoc test (*p<0.05).
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(A) Proliferation of neurospheres as indicated by determining the mean total numbers of
colonies formed per 103 cells plated from the hippocampus of 21 day-old and 1 yr-old mice
48 h post-TMT (2.3 mg/kg, i.p.) or saline. Data represents mean ± SD (n=2). (B-C)
Representative images of neurospheres obtained from the hippocampus of (B) 21 day-old or
(C) 1 yr-old mice. Scale bar = 100 μm.
(D) qRT-PCR for mRNA levels of IL-1R1, IL-RAcP, IL-6Rα, and gp130 within
neurospheres isolated from the hippocampus of 21 day or 1 yr-old mice. Data represents
mean ± SEM transcript level relative to GAPDH (*p<0.05).
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Differential effects of 21 day exposure to recombinant mouse (A) IL-1α [150 pg/ml], (B)
IL-6 [10 ng/ml], or (C) IL-1α [150 pg/ml] and IL-6 [10 ng/ml] protein on neural colony
formation. Data represents the mean total colony number per 103 cells plated ± SEM. Data
(A,B) was analyzed by a 2×2 ANOVA followed by Bonferonni post hoc test or (C) Student
t-test (*p < 0.05).
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ANOVA was used to identify genes differentially expressed in TMT-treated versus saline-
treated SGZs while taking into account the age-related interaction. (A) Venn diagram
represents differentially expressed genes (1.2-fold or greater) by two-way error weighted
ANOVA (ANOVA p<0.001 with Benjamini-Hochberg FDR p<0.05). (B) Graphical
representation of differentially expressed genes following TMT-induced injury in 21 day-old
versus 1 yr-old mice created using Pathway Archictect. Genes were then further analyzed
using the categories of binding, expression, metabolism, promoter binding, protein
modification and regulation (see legend). In this analysis, age was considered a mediator of
injury related differential expression patterns using ANOVA. These data suggest key
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molecules in the IL-6 signaling pathway are upregulated (grey ovals) in the 1 yr-old SGZ
following injury. Alternatively, IL-1α pathway genes are upregulated (white ovals) in the
young SGZ following injury.
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Table 1
Quantitative Real-Time PCR Primer Sequences
Gene Forward Primer (Concentration) Reverse Primer (Concentration)
gp130 ATTTGTGTGCTGAAGGAGGC (300 nM) AAAGGACAGGATGTTGCAGG (300 nM)
AG-I TTGGCAAGGTGATGGAAGAGACCT (300 nM) CGAAGCAAGCCAAGGTTAAAGCCA (300 nM)
GAPDH GGGAAGCTCACTGGCATGG (300 nM) CTTCTTGATGTCATCATACTTGGCAG (300 nM)
GFAP ACCGCTTTGCTAGCTACATCGAGA (900 nM) TTCTCTCCAAATCCACACGCCA (900 nM)
Iba-1 TGTGGAAGTGATGCCTGGGAGTTA (50 nM) TCAAGTTTGGACGGCAGATCCTCA (300 nM)
IL-1α TCGGGAGGAGACGACTCTAA (600 nM) GGCAACTCCTTCAGCAACAC (600 nM)
IL-1β TGGTGTGTGACGTTCCCATT (300 nM) CAGCACGAGGCTTTTTTGTTG (300 nM)
IL-1R1 CGGCGCATGTGCAGTTAA (300 nM) GCCCCCGATGAGGTAATT (300 nM)
IL-1RAcP TTGGATACAAGGTGTGCATCTTC (300 nM) GCTGAGGGTCTCATCTGTGAC (300 nM)
IL-6 TCCTACCCCAATTTCCAA (300 nM) CGTACTAGGGCCCAG (300 nM)
IL-6Rα GGTGGCCCAGTACCAATG (300 nM) GGACCTGGACCACGTGCT (300 nM)
IL-10 GGTTGCCAAGCCTTATCGGA (300 nM) ACCTGCTCCACTGCCTTGCT (300 nM)
TGFβ1 GCTCACTGCTCTTGTGACAGCAAA (300 nM) TGTACTGTGGTCCAGGCTCCAAA (300 nM)
YM-1 AGGAAGCCCTCCTAAGGACAAACA (300 nM) ATGCCCATATGCTGGAAATCCCAC (300 nM)
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